Oncogenic transformation of normal breast epithelial cells co-cultured with cancer cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncogenic transformation of normal breast epithelial cells co-cultured with cancer cells
Authors
Keywords
-
Journal
CELL CYCLE
Volume -, Issue -, Pages 1-14
Publisher
Informa UK Limited
Online
2018-08-31
DOI
10.1080/15384101.2018.1511510
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IGFBP2 Activates the NF-κB Pathway to Drive Epithelial–Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma
- (2016) Song Gao et al. CANCER RESEARCH
- Endocrine treatment in breast cancer: Cure, resistance and beyond
- (2016) Konstantinos Tryfonidis et al. CANCER TREATMENT REVIEWS
- Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications
- (2016) Silvia Juliana Serrano-Gomez et al. Molecular Cancer
- Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatment
- (2016) Niamh E. Buckley et al. Scientific Reports
- How cancer cells hijack DNA double-strand break repair pathways to gain genomic instability
- (2015) P. A. Jeggo et al. BIOCHEMICAL JOURNAL
- Clonal Evolution in Cancer: A Tale of Twisted Twines
- (2015) Michalina Janiszewska et al. Cell Stem Cell
- Carcinoma cells induce lumen filling and EMT in epithelial cells through soluble E-cadherin-mediated activation of EGFR
- (2015) P. U. Patil et al. JOURNAL OF CELL SCIENCE
- Toward understanding and exploiting tumor heterogeneity
- (2015) Ash A Alizadeh et al. NATURE MEDICINE
- HER2 Heterogeneity Affects Trastuzumab Responses and Survival in Patients With HER2-Positive Metastatic Breast Cancer
- (2014) Hee Jin Lee et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis
- (2014) Sonia A. Melo et al. CANCER CELL
- Evolution of the Cancer Stem Cell Model
- (2014) Antonija Kreso et al. Cell Stem Cell
- Breast cancer adaptive resistance: HER2 and cancer stem cell repopulation in a heterogeneous tumor society
- (2013) Nadire Duru et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- ErbB2 Activation Upregulates Glutaminase 1 Expression Which Promotes Breast Cancer Cell Proliferation
- (2013) Shuo Qie et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Cellular Heterogeneity and Molecular Evolution in Cancer
- (2012) Vanessa Almendro et al. Annual Review of Pathology-Mechanisms of Disease
- Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance
- (2012) Yi-ling Yang et al. BREAST CANCER RESEARCH AND TREATMENT
- Intratumor Heterogeneity: Evolution through Space and Time
- (2012) C. Swanton CANCER RESEARCH
- Evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue
- (2012) Steven J Potts et al. LABORATORY INVESTIGATION
- Clonal evolution in cancer
- (2012) Mel Greaves et al. NATURE
- EMT as the ultimate survival mechanism of cancer cells
- (2012) Neha Tiwari et al. SEMINARS IN CANCER BIOLOGY
- Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
- (2011) C. L. Chaffer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Delineating Genetic Alterations for Tumor Progression in the MCF10A Series of Breast Cancer Cell Lines
- (2010) Mitsutaka Kadota et al. PLoS One
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Estrogen Receptor, Progesterone Receptor, HER-2, and Response to Postmastectomy Radiotherapy in High-Risk Breast Cancer: The Danish Breast Cancer Cooperative Group
- (2008) Marianne Kyndi et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started